Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Annaly Capital Management Announces Public Offering Of Series D Preferred Stock

RELATED NEWS
Trade NLY now with 

Annaly Capital Management Inc. (NLY: Quote) announced that it plans to make a public offering of shares of an original issuance of Series D Cumulative Redeemable Preferred Stock, liquidation preference $25.00 per share.

The company said it intends to grant the underwriters of the Series D Preferred Stock a 30 day option to purchase additional shares of Series D Preferred Stock solely to cover over-allotments.

The company expects to use the proceeds of this offering to purchase mortgage-backed securities for its investment portfolio and for general corporate purposes, which may include the retirement of its long-term indebtedness, additional investments and repayment of short term indebtedness.

Click here to receive FREE breaking news email alerts for Annaly Capital Management Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.